2018
DOI: 10.1016/j.htct.2017.08.001
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and epidemiological profile of alloimmunized and autoimmunized multi-transfused patients against red blood cell antigens in a blood center of Minas Gerais

Abstract: BackgroundThe large diversity of red blood cell antigens favors, especially in multi-transfused patients, the occurrence of autoimmunization and alloimmunization with the risk of hemolytic transfusion reactions. Thus, this study aimed to determine the rates of alloimmunization and autoimmunization in these individuals, as well as the types of alloantibodies and their systems, clinical and epidemiological aspects and the frequency of autoimmunity in alloimmunized and non-alloimmunized patients.MethodsIn a retro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 19 publications
0
4
0
Order By: Relevance
“…For example, in a study of 153 polytransfused patients in Minas Gerais, Brazil, a higher frequency of anti-E (21.87%) and anti-K (21.87%) was observed. 16 Another study of 227 polytransfused patients in Sao Paulo, Brazil, reported the highest findings to be anti-E (22.06%), anti-D (13.18%), and anti-K (11.75%). 17 Meanwhile, in a study of 152 transfused patients from Medellín, Colombia, it was observed that the vast majority of antibodies in the samples could not be identified (23.68%), followed by the presence of anti-E (17.10%), autoantibodies (11.18%), and anti-K (10.53%).…”
Section: Discussionmentioning
confidence: 97%
“…For example, in a study of 153 polytransfused patients in Minas Gerais, Brazil, a higher frequency of anti-E (21.87%) and anti-K (21.87%) was observed. 16 Another study of 227 polytransfused patients in Sao Paulo, Brazil, reported the highest findings to be anti-E (22.06%), anti-D (13.18%), and anti-K (11.75%). 17 Meanwhile, in a study of 152 transfused patients from Medellín, Colombia, it was observed that the vast majority of antibodies in the samples could not be identified (23.68%), followed by the presence of anti-E (17.10%), autoantibodies (11.18%), and anti-K (10.53%).…”
Section: Discussionmentioning
confidence: 97%
“…In this issue of Hematology, Transfusion and Cell Therapy, do Valle-Neto et al describe the alloimmunization profile of a cohort of multi-transfused patients from Minas Gerais, including both sickle cell disease (SCD) and non-SCD patients. 3 The group reported a significant prevalence of autoantibodies within the cohort (6.54%), which was much higher in the group of alloimmunized patients (29.16%) in comparison to the non-alloimmunized group (2.32%). This data elegantly reinforces previous evidence in the literature regarding the high frequency of RBC autoantibodies among alloimmunized patients under chronic transfusion therapy, and highlights that both alloantibodies and autoantibodies are probably formed through similar paths of adaptive immune response.…”
mentioning
confidence: 85%
“…44,[50][51][52] Although the development of these autoantibodies is less frequent compared to the development of alloantibodies, they can cause clinically significant haemolysis and difficulty in obtaining compatible RBC units. 53 The most common antibodies observed in patients with SCD and homozygous β-thalassaemia are those against the rhesus (Rh), particularly the C and E antigens, and the Kell (K) systems. 54 Other antibodies that tend to develop are against the Kidd, Duffy, Lewis and MNS systems.…”
Section: 43mentioning
confidence: 99%